IACCINO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.440
AS - Asia 1.238
EU - Europa 829
SA - Sud America 173
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 31
OC - Oceania 3
Totale 4.828
Nazione #
US - Stati Uniti d'America 2.327
SG - Singapore 636
IT - Italia 419
CN - Cina 281
BR - Brasile 134
DE - Germania 115
VN - Vietnam 109
IN - India 91
GB - Regno Unito 70
CA - Canada 69
FI - Finlandia 53
SE - Svezia 49
HK - Hong Kong 30
MX - Messico 22
BD - Bangladesh 21
FR - Francia 19
ES - Italia 13
NL - Olanda 13
ZA - Sudafrica 13
CZ - Repubblica Ceca 12
PL - Polonia 12
AR - Argentina 11
JP - Giappone 11
RU - Federazione Russa 11
ID - Indonesia 10
KR - Corea 10
UA - Ucraina 10
CR - Costa Rica 7
PK - Pakistan 7
EC - Ecuador 6
IQ - Iraq 6
LT - Lituania 6
MA - Marocco 6
AT - Austria 5
CL - Cile 5
CO - Colombia 5
PE - Perù 5
RO - Romania 5
GT - Guatemala 4
NP - Nepal 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
KE - Kenya 3
MY - Malesia 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
ET - Etiopia 2
HN - Honduras 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
UY - Uruguay 2
AI - Anguilla 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.715
Città #
San Jose 425
Singapore 285
Dallas 279
Ashburn 252
Chandler 148
Santa Clara 96
Munich 91
Council Bluffs 72
Catanzaro 71
Hefei 68
Bengaluru 67
Beijing 58
Milan 53
Princeton 46
Ho Chi Minh City 45
Lawrence 43
London 41
Turku 41
Chicago 37
Los Angeles 34
Hong Kong 28
Ottawa 27
Phoenix 24
Boardman 23
Wilmington 23
São Paulo 21
Napoli 16
Naples 15
Seattle 15
Montreal 14
Brooklyn 13
Hanoi 13
New York 13
Helsinki 12
Olomouc 12
Redmond 12
Des Moines 11
Rome 11
Shanghai 11
Mexico City 10
Denver 9
Johannesburg 9
Warsaw 9
Hanover 8
Boston 7
San Francisco 7
Toronto 7
Atlanta 6
Augusta 6
Aversa 6
Buffalo 6
Guangzhou 6
Haiphong 6
Houston 6
Madison 6
Padova 6
Palermo 6
Seoul 6
Taranto 6
Biên Hòa 5
Boydton 5
Caserta 5
Louisville 5
Madrid 5
Norwalk 5
Orem 5
Paris 5
Providence 5
Stockholm 5
Tokyo 5
Amsterdam 4
Assago 4
Charlotte 4
Foggia 4
Huế 4
Lahore 4
Lamezia Terme 4
Latina 4
Luni 4
Manchester 4
Mumbai 4
Rio de Janeiro 4
San José 4
The Dalles 4
Athens 3
Campinas 3
Cape Town 3
Chennai 3
Chieti 3
Cleveland 3
Cosenza 3
Curitiba 3
Da Nang 3
Derby 3
Ferrara 3
Frankfurt am Main 3
Guatemala City 3
Heiwajima 3
Huddinge 3
Jiaxing 3
Totale 2.863
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 155
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 109
A novel phage display based platform for exosome diversity characterization 105
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 103
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 99
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 96
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 95
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 95
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 95
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 91
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 90
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 90
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 89
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 87
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 87
Kitcre knock-in mice fail to fate-map cardiac stem cells 86
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 83
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 82
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 81
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. 81
Cancer-associated CD43 glycoforms as target of immunotherapy 81
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 80
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 80
Collagen type V polymorphism in spontaneous quadriceps tendon ruptures 79
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 79
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 78
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 76
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 74
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 73
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 72
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 68
The aftermath of the Merck's HIV vaccine trial 68
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 68
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 68
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 67
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 66
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 66
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 65
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 64
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 64
Phage Display: An Overview in Context to Drug Discovery 63
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 61
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 60
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 60
Insights into Thymus Development and Viral Thymic Infections 58
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing 57
Belantamab mafodotin in multiple myeloma 57
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 56
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study 55
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 55
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 54
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 54
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 53
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 52
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 52
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 51
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 50
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 50
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease 50
Elotuzumab in multiple myeloma 47
Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study 46
Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's disease 46
Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease 45
Editorial: New perspectives on osteoclasts in health and disease 42
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 41
Short-term therapeutic effectiveness of tezepelumab in patients with severe asthma: A real-world study 33
Isatuximab in multiple myeloma 32
Peptide-guided targeting of GPR55 for anti-cancer therapy 29
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 27
Neurofilament Light Chain from Neuronally Derived Extracellular Vesicles in Differentiating Parkinson's Disease from Essential Tremor with Resting Tremor 20
New frontiers in porcine atrioventricular node decellularization: preserving extracellular matrix architecture for biological scaffolds 13
Emerging biomarkers in liquid biopsy: the small extracellular vesicles 9
A preanalytical quality indicator framework for automated extracellular vesicle separation 9
null 6
Totale 4.828
Categoria #
all - tutte 38.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022195 0 0 0 41 11 8 13 49 16 36 17 4
2022/2023482 89 35 30 22 44 39 13 30 86 27 50 17
2023/2024345 74 46 32 28 21 69 1 7 9 4 24 30
2024/2025985 126 36 47 27 88 98 23 19 141 35 140 205
2025/20262.085 156 217 333 205 208 115 270 109 192 158 105 17
2026/2027525 17 94 239 175 0 0 0 0 0 0 0 0
Totale 4.828